Perez-Amodio S, Jansen D C, Schoenmaker T, Vogels I M C, Reinheckel T, Hayman A R, Cox T M, Saftig P, Beertsen W, Everts V
Experimental Periodontology, Academic Center for Dentistry Amsterdam, Universiteit van Amsterdam and Vrije Universiteit, Louwesweg 1, 1066 EA Amsterdam, The Netherlands.
Calcif Tissue Int. 2006 Oct;79(4):245-54. doi: 10.1007/s00223-005-0289-z. Epub 2006 Oct 10.
Bone resorption by osteoclasts depends on the activity of various proteolytic enzymes, in particular those belonging to the group of cysteine proteinases. Next to these enzymes, tartrate-resistant acid phosphatase (TRAP) is considered to participate in this process. TRAP is synthesized as an inactive proenzyme, and in vitro studies have shown its activation by cysteine proteinases. In the present study, the possible involvement of the latter enzyme class in the in vivo modulation of TRAP was investigated using mice deficient for cathepsin K and/or L and in bones that express a high (long bone) or low (calvaria) level of cysteine proteinase activity. The results demonstrated, in mice lacking cathepsin K but not in those deficient for cathepsin L, significantly higher levels of TRAP activity in long bone. This higher activity was due to a higher number of osteoclasts. Next, we found considerable differences in TRAP activity between calvarial and long bones. Calvarial bones contained a 25-fold higher level of activity than long bones. This difference was seen in all mice, irrespective of genotype. Osteoclasts isolated from the two types of bone revealed that calvarial osteoclasts expressed higher enzyme activity as well as a higher level of mRNA for the enzyme. Analysis of TRAP-deficient mice revealed higher levels of nondigested bone matrix components in and around calvarial osteoclasts than in long bone osteoclasts. Finally, inhibition of cysteine proteinase activity by specific inhibitors resulted in increased TRAP activity. Our data suggest that neither cathepsin K nor L is essential in activating TRAP. The findings also point to functional differences between osteoclasts from different bone sites in terms of participation of TRAP in degradation of bone matrix. We propose that the higher level of TRAP activity in calvarial osteoclasts compared to that in long bone cells may partially compensate for the lower cysteine proteinase activity found in calvarial osteoclasts and TRAP may contribute to the degradation of noncollagenous proteins during the digestion of this type of bone.
破骨细胞引起的骨吸收依赖于多种蛋白水解酶的活性,尤其是属于半胱氨酸蛋白酶类的酶。除了这些酶之外,抗酒石酸酸性磷酸酶(TRAP)也被认为参与了这一过程。TRAP以无活性的酶原形式合成,体外研究表明它可被半胱氨酸蛋白酶激活。在本研究中,利用组织蛋白酶K和/或L缺陷的小鼠以及表达高水平(长骨)或低水平(颅骨)半胱氨酸蛋白酶活性的骨骼,研究了后一类酶在体内对TRAP调节中的可能作用。结果表明,在缺乏组织蛋白酶K的小鼠中,而非组织蛋白酶L缺陷的小鼠中,长骨中的TRAP活性显著更高。这种较高的活性是由于破骨细胞数量较多。接下来,我们发现颅骨和长骨之间的TRAP活性存在相当大的差异。颅骨中的活性水平比长骨高25倍。在所有小鼠中都观察到了这种差异,与基因型无关。从这两种类型的骨骼中分离出的破骨细胞显示,颅骨破骨细胞表达更高的酶活性以及该酶的更高水平的mRNA。对TRAP缺陷小鼠的分析表明,颅骨破骨细胞内及其周围未消化的骨基质成分水平高于长骨破骨细胞。最后,用特异性抑制剂抑制半胱氨酸蛋白酶活性导致TRAP活性增加。我们的数据表明,组织蛋白酶K和L在激活TRAP方面都不是必需的。这些发现还指出,不同骨部位的破骨细胞在TRAP参与骨基质降解方面存在功能差异。我们提出,与长骨细胞相比,颅骨破骨细胞中较高水平的TRAP活性可能部分补偿了颅骨破骨细胞中较低的半胱氨酸蛋白酶活性,并且TRAP可能在这类骨骼的消化过程中有助于非胶原蛋白的降解。